Take a fresh look at your lifestyle.

Canadian Pacific Railway Limited (TSE: CP) reports earnings of $ 4.74 per share for the second quarter of 2021, Desjardins Forecasts

Canadian Pacific Railway Limited (TSE: CP) (NYSE: CP) – Desjardins’ investment analysts released their 2nd quarter 2021 earnings estimates for shares in Canadian Pacific Railway in a research report for customers and investors on Thursday April 22nd , elevated. Desjardins analyst B. Poirier now expects the company to post earnings of $ 4.74 per share for the quarter, compared to its previous estimate of $ 4.71. Desjardins currently has a buy recommendation for the stock. Desjardins also released estimates for Canadian Pacific Railway’s third quarter 2021 earnings at $ 5.10 per share and fourth quarter 2021 earnings at $ 5.48 per share. The Canadian Pacific Railway (TSE: CP) (NYSE: CP) last released its quarterly results on Wednesday, January 27th. The company reported earnings of $ 5.06 per share for the quarter, beating the consensus estimate of $ 4.95 by $ 0.11. The company posted revenue of $ 2.01 billion for the quarter, compared to the consensus estimate of $ 2.08 billion.

Several other analysts recently rated the stock as well. TD Securities lowered its target price on shares of the Canadian Pacific Railway from C $ 540.00 to C $ 525.00 and issued a buy rating for the company in a research note on Thursday. National Bank Financial lowered its target price on shares of the Canadian Pacific Railway to CAD 511.00 and issued an “outperform” rating for the company in a research note on Thursday. JPMorgan Chase & Co. raised its target price on shares of the Canadian Pacific Railway from C $ 495.00 to C $ 517.00 and gave the company a “na” rating in a research note on Thursday, April 8th. National Bankshares cut its target price on shares in the Canadian Pacific Railway from C $ 515.00 to C $ 511.00 and issued a research note on Thursday that gave the company an “outperform” rating. Finally, on Wednesday, Scotiabank lowered its target price on shares of the Canadian Pacific Railway from C $ 516.00 to C $ 480.00 in a research note. Two investment analysts have rated the stock with a hold rating and seven with a buy rating. The Canadian Pacific Railway has a consensus rating of “Buy” and an average price target of $ 489.58.

(Display)

They named the 2020 crash 45 days earlier. Nobody expects what they are predicting now …

Canadian Pacific Railway shares opened Friday at $ 458.96. The company has a quick rate of 0.37, a current rate of 0.50, and a leverage ratio of 137.75. The company has a market capitalization of $ 61.18 billion and a PE ratio of 25.54. The company has a fifty day simple moving average of $ 465.07 and a two hundred day simple moving average of $ 443.43. The Canadian Pacific Railway has a twelve month low of $ 302.33 and a twelve month high of $ 489.37.

The company recently announced a quarterly dividend, which will be paid on Monday, July 26th. A dividend of $ 0.95 will be paid to shareholders of record on Friday June 25th. The ex-dividend day of this dividend is Thursday June 24th. This equates to an annualized dividend of $ 3.80 and a yield of 0.83%. The Canadian Pacific Railway’s payout ratio (DPR) is currently 19.81%.

Profile of the Canadian Pacific Railway Company

Canadian Pacific Railway Limited, together with its subsidiaries, owns and operates a transcontinental rail freight company in Canada and the United States. The company transports bulk goods such as grain, coal, potash, fertilizers and sulfur. and cargo freight such as energy, chemicals and plastics, metals, minerals, and consumer, automotive and forestry products.

See also: Does a trade war pose a risk to the global economy?

This instant message alert was generated through narrative science technology and financial data from MarketBeat to give readers the fastest, most accurate coverage possible. This story has been reviewed by the editorial staff of MarketBeat prior to publication. Please send questions or comments about this story to [email protected]

Sponsored Article: How to Build a Fibonacci Channel

7 Healthcare Stocks Deliver Innovation in 2021

We all knew that traditional health services would be disrupted in 2020. The relationship between patient and doctor became virtual. In the early months of the pandemic, many people who needed elective surgery simply did not have this option. And even local pharmacies were taking on a new e-commerce role as roadside collection or home delivery of prescription drugs became the norm.

Unsurprisingly, healthcare stocks were beaten last year. Overall, the sector fell 11%, well below the S&P 500 index, which rose over 15%.

However, the market is always future-oriented and pays special attention to innovation. There are many companies in the healthcare sector that are developing innovative approaches in areas such as gene editing. Other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That is the focus of this presentation. We have identified 7 healthcare stocks that deliver innovative ideas that help drive better patient outcomes. And in some cases, medicine will revolutionize the whole of it. These are also the stocks that analysts are watching.

Check out the “7 Healthcare Stocks That Will Innovate in 2021.”

Comments are closed.